Patent: 8,563,688
✉ Email this page to a colleague
Summary for Patent: 8,563,688
Title: | Procoagulant peptides |
Abstract: | A peptide or peptide derivative comprising: (i) WDLYFEIVW (SEQ ID NO: 1); or (ii) a variant amino acid sequence comprising one, two, three or four L-amino acid substitutions in WDLYFEIVW (SEQ ID NO: 1); or (iii) the retro-inverso variant of the peptide or peptide derivative of either one of parts (i) and (ii), wherein said peptide or peptide derivative has procoagulant activity. A peptide or peptide derivative comprising: (i) an amino acid sequence comprising imfwydcye; or (ii) a variant amino acid sequence comprising one, two, three, four, five or six amino acid substitutions in imfwydcye, wherein said peptide or peptide derivative has procoagulant activity. |
Inventor(s): | Scheiflinger; Friedrich (Vienna, AT), Dockal; Michael (Vienna, AT) |
Assignee: | Baxter International Inc. (Deerfield, IL) Baxter Healthcare SA (Glattpark (Opfikon), CH) |
Application Number: | 12/425,277 |
Patent Claims: | see list of patent claims |
Details for Patent 8,563,688
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 12/21/1979 | ⤷ Try a Trial | 2028-04-17 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 07/31/2000 | ⤷ Try a Trial | 2028-04-17 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 08/11/2005 | ⤷ Try a Trial | 2028-04-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |